According to Enochian Biosciences's latest financial reports the company has $2.94 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-06-30 | $9.17 M | -55.61% |
2021-06-30 | $20.66 M | 137.62% |
2020-06-30 | $8.69 M | -29.2% |
2019-06-30 | $12.28 M | -21.27% |
2018-06-30 | $15.6 M | 295.79% |
2017-06-30 | $3.94 M | 16767.99% |
2016-06-30 | $0.02 M | |
2014-12-31 | $3 M | |
2013-03-31 | $0 M | 1907.14% |
2012-03-31 | $0 M | |
2011-03-31 | $N/A |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 6,961.88% | ๐บ๐ธ USA |